China to cut 2,300 drug prices this month
China is to cut the prices of more than 2,300 medicines by an average of 12% on October 22, the government has announced.
Read MoreAuthor: Lynne Taylor
New threat to US pharma deal
A bid to allow US consumers to buy their drugs from Canada and elsewhere is set to return to the US Senate floor, even though it was ruled out by the PhRMA/Senate Finance Committee $80 billion cost-saving deal.
Read MoreUS Congress urged to act on biosimilars
US campaigners yesterday urged Congress to create a “real” regulatory pathway for generic versions of biologic drugs, but researchers warn that it may take until 2011 to implement any such policies.
Read MoreEU warns pharma of new competition probes
The European Commission warned the pharmaceutical industry yesterday to “look out for” new antitrust investigations over the coming months.
Read MoreUS Senate drug price disclosure row
As the US Senate Committee on Finance resumes work on its proposed health reform legislation this morning, it faces new anger over plans to require pharmacy benefit managers (PBMs) to disclose certain drug price information.
Read More- Transgene completes randomisation in phase 2 trial of tg4050
- Bayer wins MHRA approval for Kerendia in heart failure
- Oxford BioTherapeutics signs collaboration with Bristol Myers Squibb
- Kainova expands DT 7012 trial into Europe
- Amgen reports positive phase 3 results for subcutaneous TEPEZZA in thyroid eye disease
